Robert A. Verhagen

Direttore/Membro del Consiglio presso ImmunoBiochem Corp.

55 anni

Health Technology

Consumer Services

Posizioni attive di Robert A. Verhagen

Società	Posizione	Inizio	Fine
ImmunoBiochem Corp. ImmunoBiochem Corp. BiotechnologyHealth Technology ImmunoBiochem Corp. is a biopharmaceutical company founded in 2007, based in Canada. The private company is focused on developing biological therapeutics to address unmet needs in oncology and immuno-oncology. ImmunoBiochem has worked closely with the University of Toronto, one of the world's leading institutions in research and innovation, on some of its novel programs. The Canadian company uses high-throughput functional screens, bioinformatics, and AI/ML to discover novel tumor targets in the tumor microenvironment, particularly in the cancer cell secretome. The company is a Johnson & Johnson Innovation JLABS alumnus and is headquartered in the heart of Canada's largest biomedical research hub.	Direttore/Membro del Consiglio	-	-

Società	Posizione	Inizio	Fine
HELIX BIOPHARMA CORP.	Direttore/Membro del Consiglio	14/03/2012	13/05/2015
	Amministratore Delegato	30/01/2012	01/11/2015
	Presidente	30/01/2012	18/12/2014
	Presidente	30/01/2012	01/11/2015
SPECTRAL MEDICAL INC.	Corporate Officer/Principal	19/01/2010	-

University of Alberta

Masters Business Admin

Distribuzione geografica

Canada

Posizioni

Director/Board Member	2
Corporate Officer/Principal	1
Chief Executive Officer	1

Settori

Health Technology	4
Consumer Services	2

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	2
SPECTRAL MEDICAL INC.	Health Technology
HELIX BIOPHARMA CORP.	Health Technology

Aziende private	1
ImmunoBiochem Corp. ImmunoBiochem Corp. BiotechnologyHealth Technology ImmunoBiochem Corp. is a biopharmaceutical company founded in 2007, based in Canada. The private company is focused on developing biological therapeutics to address unmet needs in oncology and immuno-oncology. ImmunoBiochem has worked closely with the University of Toronto, one of the world's leading institutions in research and innovation, on some of its novel programs. The Canadian company uses high-throughput functional screens, bioinformatics, and AI/ML to discover novel tumor targets in the tumor microenvironment, particularly in the cancer cell secretome. The company is a Johnson & Johnson Innovation JLABS alumnus and is headquartered in the heart of Canada's largest biomedical research hub.	Health Technology

Aziende private

Health Technology